Product liability is the part of a beauty business that most first-time brand owners discover late, usually when a distributor asks for a certificate of insurance before placing an order. By then the question is no longer academic: without the cover, the order does not ship.
The subject also contains one of the most misunderstood points in cosmetic contract manufacturing. A brand that assumes the factory's insurance protects it, and a manufacturer that assumes the brand's insurance will respond, are both likely to be disappointed when a claim actually arrives.
This article explains how liability is allocated in the main markets, the cover types that matter, what insurers ask for, how documentation determines the outcome of a claim, and what to agree in a contract. It is a general explanation of how the arrangements work rather than insurance or legal advice, and the terms of any specific policy or contract are what govern.
Why liability sits with the brand
In the European Union the cosmetic regulation places the responsibility for compliance on the Responsible Person, which is the entity that places the product on the market under its name or trademark. In the United States the Modernization of Cosmetics Regulation Act places registration, listing, safety substantiation and adverse event obligations on the entity that markets the product. The pattern is consistent across markets: the party whose name is on the pack is the party the regulator and, in most cases, the claimant pursue first.
The manufacturer is not outside the picture. Where a defect is caused by a manufacturing error, the manufacturer may share liability, and a claimant may pursue both. But the brand is the visible party, and it is the brand's insurance that is expected to respond first. This is why a distributor's standard supplier questionnaire asks for the brand's insurance certificates rather than the factory's.
The practical consequence is that a brand should arrange insurance as a launch requirement rather than as a later addition, because several sales channels will not open without it. Marketplace platforms, large retailers and distributors all ask for evidence of cover as part of onboarding.
The cover types that matter
Several covers are relevant to a beauty brand, and they do different jobs. Bundling them into one policy is possible but the components should still be understood individually.
| Cover | What it responds to | Why a brand needs it |
|---|---|---|
| Product liability | Bodily injury or property damage caused by the product | The core cover; required by most distributors and retailers |
| Product recall and contamination | The cost of withdrawing or recalling product, including logistics and communication | Recall is often the largest single exposure and is usually excluded from standard liability cover |
| General liability | Injury or damage arising from the business's premises or operations | Relevant where the brand holds or handles stock |
| Marine cargo or stock throughput | Loss or damage to goods in transit | Cosmetics ship across borders and the exposure is often not covered by the forwarder |
| Professional indemnity | Loss caused by professional advice or design failure | Relevant where the brand specifies the formula or engages a designer |
| Cyber and data | Loss arising from a data breach | Relevant for direct-to-consumer operations holding customer data |
Two of these deserve emphasis. Product recall is separate from product liability, and a policy that covers injury claims does not automatically pay for the cost of getting product back from the market. And professional indemnity matters specifically where the brand, rather than the manufacturer, controls the formula, because that is the point at which the design decision becomes the brand's responsibility.
What insurers ask for
An underwriter assessing a cosmetic brand is trying to establish how much risk the product portfolio carries, and the questions follow from that.
They typically ask for the product categories and the markets, the annual turnover or the initial forecast, whether the products are applied to the skin or around the eyes, whether they are for children, whether any product makes a claim that edges towards a therapeutic benefit, the manufacturing arrangements and whether the manufacturer holds a recognised good manufacturing practice certification, and whether the brand owns the formula or buys a stock one.
The answers that move the premium most are the product categories, since products for children, for the eye area and for the lips carry a higher exposure; the markets, because the United States is generally treated as the most litigious; and whether the brand controls the formula. A brand using a manufacturer's proven base formula in a licensed facility presents a considerably lower risk profile than one bringing its own novel formulation to a factory.
Two documents speed the process considerably. The manufacturer's good manufacturing practice certificate and its technical documentation package both signal that the supply chain is controlled, and most underwriters will ask for them.
Recalls and the costs insurance often excludes
A recall is the scenario most likely to be financially significant and the one most likely to fall between policies.
The direct costs include retrieving product from the market, notifying customers and distributors, storing or destroying returned stock, and replacing affected product. The indirect costs include lost sales during the gap, the cost of the investigation, and the reputational damage that no policy covers. Where a regulator has ordered the withdrawal, the compliance cost is unavoidable.
Cover for recall exists but it is usually written with conditions. Two conditions matter most. The first is that the event must be discovered and notified within the policy period, which means the brand has to have a recall procedure that would detect the problem rather than a passive arrangement. The second is that the policy normally requires the brand to have batch traceability, because a recall that cannot identify which batches are affected becomes an all-product withdrawal, and insurers treat that as a materially larger exposure.
This is where insurance and manufacturing operations meet, and it is a good reason for a brand to confirm that its manufacturer maintains batch records linking raw materials to finished goods. That capability is also a regulatory expectation in most markets, so it is not an additional burden bought for insurance purposes.
Documentation is what decides a claim
An insurance policy pays out when a claim meets its terms, and the evidence that determines whether it does is the technical file.
For a cosmetic, the relevant evidence includes the safety assessment, the stability and compatibility data, the microbiological results, the batch records, the manufacturing records, the distribution records and the adverse event log. In the European Union much of this is compiled as the Product Information File and held by the Responsible Person. In the United States the safety substantiation and adverse event obligations produce comparable records.
Two practical points follow. First, a brand should be able to produce these records within days of a request, because a claim response has a clock on it and reconstructing records from a supplier after the fact is slow. Second, the records should be retained for the period the law requires in each market and for the period the insurance requires, which is not always the same, and the longer of the two is the one to follow.
Contracts, indemnities and who pays
A manufacturing agreement normally contains indemnity provisions describing who compensates whom in different scenarios, and these provisions are where the allocation of risk actually sits.
The pattern that makes sense follows the allocation of responsibility. A manufacturer indemnifies the brand for losses caused by a manufacturing defect, a deviation from the agreed specification or a breach of the agreed standards. The brand indemnifies the manufacturer for losses caused by the brand's own formula, its artwork, its claims or its marketing. Where the brand supplies the formula and the manufacturer produces it faithfully, the formula-related risk sits with the brand, which is a genuine and often overlooked exposure.
Three clauses are worth reviewing rather than accepting as standard. The first is the insurance requirement, which should specify the types and the limits each party must maintain and name the other as an additional insured where appropriate. The second is the obligation to notify the other party promptly of any claim or regulatory enquiry, because late notification can void cover. The third is the survival period of the indemnities after the agreement ends, since claims can arrive years after the last shipment.
Market-specific considerations
Several market features affect the risk picture and should be stated to an underwriter rather than discovered later.
In the European Union a revised product liability framework adopted in 2024 modernises the regime and gives member states a deadline to transpose it, which is expected to affect how claims are assessed over the coming period. The Responsible Person arrangement means that a non-EU brand selling into the Union will have a named EU entity in the chain, and the brand should be clear about what that entity's role does and does not include.
In the United States the Modernization of Cosmetics Regulation Act gives the regulator the authority to order a mandatory recall where a product is adulterated or misbranded, in addition to the voluntary recall route, and it introduces adverse event reporting obligations. The litigation environment is generally considered the most active globally, which is reflected in the premiums quoted for US exposure.
In markets where distribution is through a local importer, the importer is often the party with local liability exposure, and it will commonly require the brand to evidence insurance or to indemnify it. This should be anticipated in the commercial negotiation rather than treated as an administrative detail.
Limits, deductibles and territory
Three policy parameters determine how much protection a given premium actually buys.
The limit of indemnity is the maximum the policy will pay for a claim, and it is usually expressed as a limit per claim and in aggregate for the period. Distribution agreements frequently specify a minimum limit, so the requirement is normally set by the largest customer rather than by the brand's own assessment. The deductible is the amount the brand pays before the policy responds, and choosing a higher deductible lowers the premium at the cost of making small claims uneconomic to pursue. The territory and the jurisdiction determine where the cover applies and can be restricted, so a brand selling into the United States, Canada and the European Union needs all three expressly included.
One further parameter deserves attention: whether the policy is written on a claims-made or an occurrence basis. On a claims-made policy, the claim must be notified during the policy period, which makes continuous cover important rather than optional. A lapse of a month can leave a claim unrecoverable even if the incident occurred while cover was in force.
What should a brand prepare before approaching an underwriter?
Prepare a product schedule listing each SKU with its category and its intended markets, the forecast turnover for the next twelve months, the manufacturing arrangements including the manufacturer's name and its certification, a statement of who owns each formula, copies of the manufacturer's certificates and technical documentation package, and the insurance requirements stated in any distribution or marketplace agreement the brand intends to sign.
Two items save a great deal of time. Confirm the minimum insurance limits the brand's target channels require before agreeing on a limit, since a limit below a retailer's threshold will be rejected regardless of the premium paid. And establish whether the brand or the manufacturer controls each formula, because that single question determines which entity's professional indemnity cover, if any, would be expected to respond.
Frequently asked questions about cosmetic liability
Does the manufacturer's insurance cover us?
Only in the sense that the manufacturer's own liability may be pursued. The brand remains the primary target as the entity named on the pack, so the brand needs its own cover.
Is a recall covered by product liability insurance?
Usually not. Recall and contamination cover is normally written as a separate component or policy and carries its own conditions.
What documents will an insurer ask for?
Typically the product schedule, markets, turnover, manufacturing arrangements, the manufacturer's certification and, for the higher-risk products, the safety and stability documentation.
Do we need to keep records of every batch?
Yes, and it is a regulatory expectation as well as an insurance one. Batch traceability is what allows a recall to be targeted rather than total.
Will you provide the documents an insurer asks about manufacturing?
Yes. Our good manufacturing practice documentation, batch traceability records, safety assessments and stability data are supplied to support a brand's insurance application and its technical file.
Next step: put the documentation together before you need it
If you are preparing to launch or to sign a distribution agreement, tell us the products and markets involved and we will provide the manufacturing certification, batch traceability and technical documentation that insurers and distributors ask for. Write to capsulebiotech@163.com, message the right team on WhatsApp: Capsule Series (capsules only) +86 158-7655-5319, Cosmetics Series (serum, hair care, body care, fragrance) +86 158-7655-5319, or use the inquiry form and we will reply within one working day.
Related programmes and guides: firming face cream, amino acid facial cleanser, and our guides to manufacturing contract terms and the documents private label brands need.